Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18045
Title: Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis.
Austin Authors: Mitsios, John P;Ekinci, Elif I ;Mitsios, Gregory P;Churilov, Leonid ;Thijs, Vincent N 
Affiliation: The University of Melbourne, Parkville, Melbourne, Victoria, Australia
Austin Health, Heidelberg, Victoria, Australia
The Florey Institute of Neuroscience & Mental Health, Melbourne, Victoria, Australia
Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Department of Neurology, Austin Health, Heidelberg, Victoria, Australia
Stroke Division, The Florey Institute of Neuroscience & Mental Health University of Melbourne, Heidelberg, Victoria, Australia
Issue Date: 17-May-2018
metadata.dc.date: 2018
Publication information: Journal of the American Heart Association 2018; 7(11): e007858
Abstract: Diabetes mellitus is a major risk factor for ischemic stroke. Rising hemoglobin A1c (HbA1c) levels are associated with microvascular diabetes mellitus complication development; however, this relationship has not been established for stroke risk, a macrovascular complication. We conducted a systematic review and meta-analysis of observational cohort and nested case-control cohort studies assessing the association between rising HbA1c levels and stroke risk in adults (≥18 years old) with and without type 1 or type 2 diabetes mellitus. Random-effects model meta-analyses were used to calculate pooled adjusted hazard ratios (HRs) and their precision. The systematic review yielded 36 articles, of which 29 articles (comprising n=532 779 participants) were included in our meta-analysis. Compared to non-diabetes mellitus range HbA1c (<5.7%), diabetes mellitus range HbA1c (≥6.5%) was associated with an increased risk of first-ever stroke with average HR (95% confidence interval) of 2.15 (1.76, 2.63), whereas pre-diabetes mellitus range HbA1c (5.7-6.5%) was not (average HR [95% confidence interval], 1.19 [0.87, 1.62]). For every 1% HbA1c increment (or equivalent), the average HR (95% confidence interval) for first-ever stroke was 1.12 (0.91, 1.39) in non-diabetes mellitus cohorts and 1.17 (1.09, 1.25) in diabetes mellitus cohorts. For every 1% HbA1c increment, both non-diabetes mellitus and diabetes mellitus cohorts had a higher associated risk of first-ever ischemic stroke with average HR (95% confidence interval) of 1.49 (1.32, 1.69) and 1.24 (1.11, 1.39), respectively. A rising HbA1c level is associated with increased first-ever stroke risk in cohorts with a diabetes mellitus diagnosis and increased risk of first-ever ischemic stroke in non-diabetes mellitus cohorts. These findings suggest that more intensive HbA1c glycemic control targets may be required for optimal ischemic stroke prevention.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18045
DOI: 10.1161/JAHA.117.007858
ORCID: 0000-0003-2372-395X
0000-0002-9807-6606
0000-0002-6614-8417
PubMed URL: 29773578
Type: Journal Article
Subjects: cerebrovascular disease/Stroke
diabetes mellitus
hemoglobin A1c
meta‐analysis
risk
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on Nov 30, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.